ADVB - CIK 0001941029
The table below shows Advanced Biomed Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2025 | Q3 2024 |
|---|---|---|
| Operating cash flow | -$610.34K | -$29.68K |
| Capital expenditure | $1.77K | $19.98K |
| Investing cash flow | -$1.77K | -$19.98K |
| Dividends paid | - | - |
| Stock buybacks | - | - |
| Financing cash flow | $447.46K | $392.52K |
Advanced Biomed Inc. reported operating cash flow of -$5.83M for fiscal year 2025. That is down 173.9% from -$2.13M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.